Gender differences in patients with Sjögren’s syndrome: A 10-year single centre experience Gender differences in patients with Sjögren’s syndrome: A 10-year single centre experienceDraženka Kontek2023-05-31T10:04:37+02:00
Association of biological therapy and malignancy in inflammatory rheumatic diseases Association of biological therapy and malignancy in inflammatory rheumatic diseasesDraženka Kontek2023-05-31T10:04:02+02:00
Incidence of thromboembolic events in patients with a systemic form of vasculitis and cutaneous vasculitis Incidence of thromboembolic events in patients with a systemic form of vasculitis and cutaneous vasculitisDraženka Kontek2023-05-31T10:02:57+02:00
COVID-19 COURSE AND OUTCOME IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES WHO ARE ON BIOLOGICAL OR TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS – RESULTS FROM A SINGLE RHEUMATOLOGY CENTRE COVID-19 COURSE AND OUTCOME IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES WHO ARE ON BIOLOGICAL OR TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS – RESULTS FROM A SINGLE RHEUMATOLOGY CENTREDraženka Kontek2023-05-31T10:02:21+02:00
Diagnosis and classification criteria of Sjögren’s syndrome Diagnosis and classification criteria of Sjögren’s syndromeDraženka Kontek2023-05-31T09:59:23+02:00
Association between cutaneous manifestations and clinical features of IgA vasculitis Association between cutaneous manifestations and clinical features of IgA vasculitisDraženka Kontek2023-05-29T13:06:57+02:00
